Skip to main content
MedPathMedPath Home
Clinical Trials/ISRCTN77275134
ISRCTN77275134
Completed
N/A

A study of radiotherapy with or without chemotherapy in primary central nervous system (CNS) lymphoma

Medical Research Council (MRC) (UK)0 sites90 target enrollmentFebruary 28, 2001
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Medical Research Council (MRC) (UK)
Enrollment
90
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 28, 2001
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional

Investigators

Sponsor
Medical Research Council (MRC) (UK)

Eligibility Criteria

Inclusion Criteria

  • •1\. Pathologically proven primary cerebral lymphoma
  • •2\. Aged 18\-75
  • •3\. No previous radiotherapy or chemotherapy
  • •4\. Adequate neurological, physical and mental function

Exclusion Criteria

  • •Not provided at time of registration

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
ChemoRadiotherapy with Or Without surgery followed by consolidation Durvalumab (CROWD): a phase IV feasibility trialStage III non-small cell lung cancerTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]Therapeutic area: Diseases [C] - Neoplasms [C04]
CTIS2024-511711-21-00Amsterdam UMC Stichting38
Completed
Phase 3
A randomized trial of chemoradiotherapy and chemotherapy for locally advanced pancreatic cancer
JPRN-UMIN000001923Department of Surgical Oncology and HBP Surgery, Kagoshima University Graduate School100
Completed
Phase 3
Short-term radiotherapy versus chemoradiotherapy followed by consolidating chemotherapy and selective organ preservation for Patients with MRI-defined intermediate and high riskC20Malignant neoplasm of rectum
DRKS00020770Klinik für Strahlentherapie Universitätsklinikum Frankfurt/M702
Completed
Phase 2
A phase II study of chemoradiotherapy with use of involved-field conformal radiotherapy and accelerated hyperfractionation for Stage III non-small cell lung cancerStage III non-small cell lung cancer
JPRN-UMIN000010428West Japan Oncology Group44
Completed
N/A
Study of alternating chemoradiotherapy combined with proton beam therapy and intra-arterial infusion chemotherapy for advanced tongue cancerlocally advenced tongue cancer
JPRN-UMIN000032732Department of radiation oncology, Southern Tohoku Proton Therapy Center30